<dl id="5y4e6"><noframes id="5y4e6"></noframes></dl>

    1. 公司研發(fā)團隊在全球頂級學術期刊《Nature Materials》、《Nature Communications、《Cell Research等系列發(fā)表“載藥囊泡治療腫瘤技術”相關文章20余篇,引用次數(shù)高達4000余次,最高單篇影響因子達38以上。


      2020.07
      題為
      Chemotherapeutic Tumor Microparticles Elicit a Neutrophil Response Targeting Malignant Pleural Effusions在 Cancer Immunology Research 雜志上發(fā)表。 (IF: 8.728 )


      2020.07
      題為
      Mobilization of neutrophils by MTX-packaging tumor microparticles confers treatment efficacy for obstructive cholangiocarcinoma Nature Biomedical Engineering雜志上發(fā)表。 (IF: 18.952 )


      2019.10
      題為
      Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1&beta; Cellular & Molecular Immunology 雜志上發(fā)表。 (IF: 8.484)


      2019.05
      題為
      The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency Nature Biomedical Engineering 雜志上發(fā)表。 (IF: 18.952) 

      2019.01
      題為
      Autologous tumor cell&ndash;derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion 在 Science Translational Medicine 雜志上發(fā)表。 (IF: 16.304) 
      2018.09
      2018.09
      題為Mechanisms underlying presentation of tumor microparticle antigens to CD8+ T cells by dendritic cells在 Cancer Immunology Research 雜志上發(fā)表。(IF: 8.728
      2017.03
      2017.01
      2017.01
      2016.06
      2016 .05
      2016 .02
      2015 .05
      題為Tumor cell-derived microparticles: a new form of cancer vaccine在 Oncoimmunology 雜志上發(fā)表。(IF: 5.869)
      2015 .04
      題為Microparticles mediate human papillomavirus type 6 or 11 infection of human macrophages 在 Cellular & Molecular Immunology 雜志上發(fā)表。(IF: 8.484)
      2015 .02
      題為Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling 在 Cancer Immunology Research 雜志上發(fā)表。(IF: 8.728)
      2012 .12
      題為Delivery of chemotherapeutic drugs in tumourcell-derived microparticles Nature Communications上發(fā)表。 (IF: 12.121)
      2012.10
      2012 .08
      2010 .10